BRIEF published on 04/08/2025 at 08:05, 11 months 15 days ago Quantum Genomics : Situation Actuelle et Défis Financiers Biotechnologie Levée De Fonds Situation Financière Suspension Cotation Réadmission Actions
BRIEF published on 04/08/2025 at 08:05, 11 months 15 days ago Quantum Genomics: Current Situation and Financial Challenges Biotechnology Fundraising Financial Situation Suspension Of Quotation Readmission Of Actions
BRIEF published on 04/08/2025 at 08:05, 11 months 15 days ago Pulsar Helium Secures $4 Million Credit for Minnesota Project Helium Exploration Pulsar Helium Topaz Project Finance Facility Keewaydin Resources
BRIEF published on 04/08/2025 at 08:05, 11 months 15 days ago Pulsar Helium obtient un crédit de 4 millions de dollars pour un projet au Minnesota Pulsar Helium Exploration De L'hélium Projet Topaze Facilité De Financement Ressources Keewaydin
BRIEF published on 04/08/2025 at 08:05, 11 months 15 days ago University Hospital Zurich Evaluates Steriwave for Surgical Use Antimicrobial Resistance Nasal Decolonization Steriwave Surgical Site Infections University Hospital Zurich
BRIEF published on 04/08/2025 at 08:05, 11 months 15 days ago L'hôpital universitaire de Zurich évalue Steriwave pour une utilisation chirurgicale Steriwave Infections Du Site Opératoire Résistance Aux Antimicrobiens Décolonisation Nasale Hôpital Universitaire De Zurich
BRIEF published on 04/08/2025 at 07:51, 11 months 15 days ago GenSight Biologics Dépose son Document d’Enregistrement Universel 2024 AMF Thérapie Génique Document D'enregistrement GenSight Biologics Rétine
BRIEF published on 04/08/2025 at 07:51, 11 months 15 days ago GenSight Biologics Files its 2024 Universal Registration Document AMF Gene Therapy Registration Document GenSight Biologics Retina
BRIEF published on 04/08/2025 at 07:50, 11 months 15 days ago COGRA : Reprise de la Croissance au 3ème Trimestre 2024/25 Chiffre D'affaires Croissance Marché Transition Granulés De Bois
BRIEF published on 04/08/2025 at 07:50, 11 months 15 days ago COGRA: Growth to Resume in the 3rd Quarter of 2024/25 Growth Turnover Transition Walk Wood Pellets
Published on 03/23/2026 at 08:00, 2 hours 8 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 8 hours 8 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 09:19, 49 minutes ago Mister Spex Chooses Salesforce to further develop its Omnichannel Strategy
Published on 03/23/2026 at 09:00, 1 hour 8 minutes ago EQS Group launches Risk Management module to support continuous data and AI risk oversight
Published on 03/23/2026 at 08:10, 1 hour 58 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 15 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 15 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 15 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 15 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
